Safety Study of an Antipsychotic, Sertindole, to Treat Schizophrenia

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

July 31, 2010

Study Completion Date

October 31, 2010

Conditions

Schizophrenia

Interventions

DRUG

Sertindole

Flexible dose

Trial Locations (1)

FR002, Allonnes

All Listed Sponsors

lead

H. Lundbeck A/S

INDUSTRY

NCT00763438 - Safety Study of an Antipsychotic, Sertindole, to Treat Schizophrenia | Biotech Hunter | Biotech Hunter